A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease)
- PMID: 10440905
A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease)
Abstract
The human hereditary ceroid-lipofuscinoses are a group of autosomal recessively inherited diseases characterized by massive accumulations of autofluorescent lysosomal storage bodies in the cells of many tissues and by neuronal degeneration throughout the central nervous system. There are a number of clinically and genetically distinct forms of ceroid-lipofuscinosis, the most common of which is the juvenile type, also known as Batten disease and CLN3. To study the mechanisms that lead to pathology in CLN3 and to evaluate potential therapies, a mouse model has been generated by targeted disruption of the mouse ortholog of the CLN3 gene (Cln3). As in affected humans, mice homozygous for the disrupted Cln3 allele show accumulation of autofluorescent storage material in neurons and other cell types. The storage material consists of membrane-bounded intracellular inclusions with ultrastructural features typical of the ceroid-lipofuscinoses. The accumulation of this storage material validates the Cln3 knockout mice as a model for the human disorder.
Copyright 1999 Wiley-Liss, Inc.
Similar articles
-
Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).Mol Cell Neurosci. 2002 Apr;19(4):515-27. doi: 10.1006/mcne.2001.1099. Mol Cell Neurosci. 2002. PMID: 11988019
-
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].Neurobiol Dis. 1999 Oct;6(5):321-34. doi: 10.1006/nbdi.1999.0267. Neurobiol Dis. 1999. PMID: 10527801
-
Altered gene expression in the eye of a mouse model for batten disease.Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2893-905. doi: 10.1167/iovs.04-0143. Invest Ophthalmol Vis Sci. 2004. PMID: 15326100
-
Moving towards therapies for juvenile Batten disease?Exp Neurol. 2008 Jun;211(2):329-31. doi: 10.1016/j.expneurol.2008.02.016. Epub 2008 Mar 4. Exp Neurol. 2008. PMID: 18400221 Review.
-
Molecular genetic analysis of neuronal ceroid lipofuscinosis.Int J Neurol. 1991-1992;25-26:52-9. Int J Neurol. 1991. PMID: 11980063 Review.
Cited by
-
[NCL in animal models].Ophthalmologe. 2010 Jul;107(7):621-7. doi: 10.1007/s00347-009-2108-9. Ophthalmologe. 2010. PMID: 20454900 German.
-
Selectivity and types of cell death in the neuronal ceroid lipofuscinoses.Brain Pathol. 2004 Jan;14(1):86-96. doi: 10.1111/j.1750-3639.2004.tb00502.x. Brain Pathol. 2004. PMID: 14997941 Free PMC article. Review.
-
Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.Neurobiol Dis. 2008 Feb;29(2):242-53. doi: 10.1016/j.nbd.2007.08.017. Epub 2007 Sep 7. Neurobiol Dis. 2008. PMID: 17962032 Free PMC article.
-
A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.J Neurosci. 2004 Oct 13;24(41):9117-26. doi: 10.1523/JNEUROSCI.2729-04.2004. J Neurosci. 2004. PMID: 15483130 Free PMC article.
-
Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis.Elife. 2017 Nov 14;6:e28685. doi: 10.7554/eLife.28685. Elife. 2017. PMID: 29135436 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials